Terns Pharmaceuticals (TERN) Other Non-Current Assets: 2020-2022

Historic Other Non-Current Assets for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $37,000.

  • Terns Pharmaceuticals' Other Non-Current Assets fell 25.53% to $35,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $35,000, marking a year-over-year decrease of 25.53%. This contributed to the annual value of $37,000 for FY2022, which is 60.64% down from last year.
  • As of FY2022, Terns Pharmaceuticals' Other Non-Current Assets stood at $37,000, which was down 60.64% from $94,000 recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Other Non-Current Assets registered a high of $246,000 during FY2020, and its lowest value of $37,000 during FY2022.
  • Its 3-year average for Other Non-Current Assets is $125,667, with a median of $94,000 in 2021.
  • Data for Terns Pharmaceuticals' Other Non-Current Assets shows a maximum YoY plummeted of 61.79% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Terns Pharmaceuticals' Other Non-Current Assets stood at $246,000 in 2020, then tumbled by 61.79% to $94,000 in 2021, then plummeted by 60.64% to $37,000 in 2022.